Effects of 6-hydroxydopamine on central noradrenaline neurons during ontogeny.

Brain Research
C Sachs, G Jonsson

Abstract

The effects of the catecholamine neurotoxic compound, 6-hydroxydopamine (6-OHDA) have been investigated on central noradrenaline (NA) neurons after neonatal administration. In agreement with previous studies this treatment (1-3 X 100 mg/kg) led to a pronounced reduction of the in vitro uptake of [3H]NA and the endogenous NA in the cerebral cortex, while these parameters were markedly augmented in the pons and medulla oblongata, regions containing the NA perikarya. The 6-OHDA induced changes in the cerebral cortex and the pons-medulla could be completely prevented by the 'membrane pump' blocker desipramine, indicating that the effects are associated with a specific neurotoxic action of 6-OHDA on the NA neurons. Consistently, 6-OHDA acutely (within 2 h) produced a marked reduction of the [3H]NA uptake in both the cerebral cortex and pons-medulla. In the cerebral cortex the nadir (approximately 75% reduction) was reached within 6 h and remained so, while in the pons-medulla the [3H]NA uptake rapidly recovered, being maximally elevated after 14 days (50-80% increase) and remained so for at least 6 months. The [3H]NA uptake in the pons-medulla from 6-OHDA treated rats had the same kinetic and pharmacological properties as that of c...Continue Reading

References

Jan 1, 1971·Acta Physiologica Scandinavica. Supplementum·U Ungerstedt
Jul 1, 1970·The Journal of Pharmacy and Pharmacology·K D Evetts, L L Iversen
Jul 15, 1972·Life Sciences. Pt. 1: Physiology and Pharmacology·B A Pappas, S K Sobrian
Feb 1, 1972·British Journal of Pharmacology·D W ClarkE L Phelan
Jun 1, 1973·Journal of Neurochemistry·C Sachs
Oct 1, 1973·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·C Sachs, G Jonsson
Dec 1, 1971·Journal of Neurochemistry·D G JohnsonI J Kopin
May 1, 1971·British Journal of Pharmacology·G R Breese, T D Traylor
Jun 1, 1969·Brain Research·G Raisman
Jan 1, 1966·Psychopharmacologia·H Corrodi, L C Hanson
Dec 15, 1958·Acta Physiologica Scandinavica·A BERTLERE ROSENGREN

❮ Previous
Next ❯

Citations

Jan 1, 1979·Anatomy and Embryology·R Loy, R Y Moore
Feb 21, 1998·Biulleten' eksperimental'noĭ biologii i meditsiny·V N IaryginI E Malinina
Oct 1, 1979·European Journal of Pharmacology·L M Zieher, G Jaim-Etcheverry
May 6, 1996·European Journal of Pharmacology·A GorioA M Di Giulio
Aug 1, 1978·Journal of the Neurological Sciences·E BendeichG R Breese
Aug 1, 1981·Pharmacology, Biochemistry, and Behavior·M E Olds, J L Fobes
Feb 18, 1994·Brain Research. Developmental Brain Research·M C Osterheld-HaasJ P Hornung
Jul 1, 1976·Brain Research Bulletin·W J Freed
Jan 1, 1990·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·J LuthmanG Jonsson
Mar 5, 1999·Brain Research. Developmental Brain Research·S Z NaquiJ G Parnavelas
Jul 8, 2000·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·I PodkletnovaE R Korpi
Feb 28, 2001·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·I PodkletnovaH Alho
Jul 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·P Levitt, J L Noebels
Dec 24, 1984·Brain Research·R L McBride, J Sutin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.